Trial Profile

A Phase One Open-Label Single-Radiolabeled Dose Study To Investigate The Absorption, Metabolism And Excretion Of [14C]PF-00299804 in Healthy Male Volunteers.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 19 Dec 2018

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dacomitinib (Primary)
Indications Head and neck cancer; Non-small cell lung cancer; Solid tumours
Focus Adverse reactions; Pharmacokinetics
Sponsors Pfizer

Most Recent Events

02 Apr 2011 Results will be presented at the Annual Meeting of the American Association for Cancer Research (AACR-2011).
11 Mar 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
12 Feb 2010 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com